부산대학교 도서관

Parker CC; Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, UK. Electronic address: chris.parker@rmh.nhs.uk.; Petersen PM; Department of Oncology, Copenhagen Prostate Cancer Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester; Manchester Cancer Research Centre, The University of Manchester, Manchester; Department of Urology, Salford Royal NHS Foundation Trust, Manchester, UK, Department of Urology, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.; Catton C; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Cross WR; Department of Urology, St James's University Hospital, Leeds.; Kynaston H; Division of Cancer and Genetics, Cardiff University, Cardiff, UK.; Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, Canada.; Persad RA; Department of Urology, Bristol Urological Institute, Bristol, UK.; Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Canada.; Bower L; Guy's and St Thomas' NHS Foundation Trust, London; Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, UK.; Durkan GC; Department of Urology, University Hospital Galway, Galway, Ireland.; Logue J; Department of Oncology, The Christie Hospital NHS FT, Wilmslow Road, Manchester.; Maniatis C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Noor D; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Payne H; The Prostate Centre, London.; Anderson J; St James's Institute of Oncology, Leeds.; Bahl AK; Bristol Haematology and Oncology Centre, University Hospitals Bristol & Weston NHS Trust, Bristol.; Bashir F; Queen's Centre for Oncology, Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.; Bottomley DM; St James's Institute of Oncology, Leeds.; Brasso K; Department of Urology, Copenhagen Prostate Cancer Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Capaldi L; Worcester Oncology Centre, Worcestershire Acute NHS Hospitals Trust, Worcester.; Chung C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Cooke PW; Department of Urology, The Royal Wolverhampton NHS Trust, Wolverhampton.; Donohue JF; Department of Urology, Maidstone and Tunbridge Wells NHS Trust, Maidstone.; Eddy B; East Kent University Hospitals Foundation Trust, Kent.; Heath CM; Department of Clinical Oncology, University Hospital Southampton NHS Foundation Trust, Southampton.; Henderson A; Department of Urology, Maidstone and Tunbridge Wells NHS Trust, Maidstone.; Henry A; Leeds Institute of Medical Research, University of Leeds, Leeds.; Jaganathan R; Department of Urology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Jakobsen H; Department of Urology, Herlev University Hospital, Herlev, Denmark.; James ND; Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, UK.; Joseph J; Leeds Teaching Hospitals; York and Scarborough Teaching Hospitals, York.; Lees K; Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Maidstone.; Lester J; South West Wales Cancer Centre, Singleton Hospital, Swansea, UK.; Lindberg H; Department of Oncology, Herlev University Hospital, Herlev, Denmark.; Makar A; Department of Urology, Worcestershire Acute Hospitals Trust, Worcester.; Morris SL; Guy's and St Thomas' NHS Foundation Trust, London.; Oommen N; Wrexham Maelor Hospital, Wrexham.; Ostler P; Department of Urology, Hillingdon Hospitals NHS Foundation Trust, Hillingdon, London.; Owen L; Bradford Royal Infirmary, Bradford; Leeds Cancer Centre, Leeds.; Patel P; Department of Urology, University College London Hospitals, London.; Pope A; Department of Urology, Hillingdon Hospitals NHS Foundation Trust, Hillingdon, London.; Popert R; Guy's and St Thomas' NHS Foundation Trust, London.; Raman R; Kent Oncology Centre, Kent & Canterbury Hospital, Canterbury.; Ramani V; Department of Urology, The Christie NHS Foundation Trust, Manchester.; Røder A; Department of Urology, Copenhagen Prostate Cancer Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen.; Sayers I; Deanesly Centre, New Cross Hospital, Wolverhampton.; Simms M; Department of Urology, Hull University Hospitals NHS Trust, Hull.; Srinivasan V; Glan Clwyd Hospital, Betsi Cadwaladr University Health Board, Rhyl.; Sundaram S; Department of Urology, Mid Yorkshire Teaching Hospital, Wakefield.; Tarver KL; Department of Oncology, Queen's Hospital, Romford.; Tran A; Department of Oncology, The Christie Hospital NHS FT, Wilmslow Road, Manchester.; Wells P; Barts Cancer Centre, St Bartholomews Hospital, London.; Wilson J; Royal Gwent Hospital, Newport.; Zarkar AM; Department of Oncology, University Hospitals Birmingham, Birmingham, UK.; Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London. Electronic address: mrcctu.radicals@ucl.ac.uk.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Kwak L; Dana-Farber Cancer Institute, Boston, MA.; Ravi P; Dana-Farber Cancer Institute, Boston, MA.; Armstrong JG; Radiation Oncology Department, Cancer Trials Ireland, St Luke's Hospital, Dublin, Ireland.; Beckendorf V; Institut de cancérologie de Lorraine, Nancy, France.; Chin JL; Western University, London, ON, Canada.; D'Amico AV; Brigham and Women's Hospital, Boston, MA.; Dearnaley DP; The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Di Stasi SM; Department of Urology, Catholic University, Rome, Italy.; Gillessen S; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Lukka H; McMaster University and Juravinski Cancer Centre, Hamilton, ON, Canada.; Mottet N; Mutualite Francoise Loire, St Etienne, France.; Pommier P; Institut de Cancérologie de l'Ouest, Angers, France.; Seiferheld W; NRG Oncology, Philadelphia, PA.; Sydes MR; Medical Research Council at UCL, London, United Kingdom.; Tombal B; Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Zapatero A; Department of Radiation Oncology, La Princesa University Hospital, Health Research Institute, Madrid, Spain.; Regan MM; Dana-Farber Cancer Institute, Boston, MA.; Xie W; Dana-Farber Cancer Institute, Boston, MA.; Sweeney CJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, Australia.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Parker CC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Urology, Salford Royal Hospital, Salford, UK.; Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Kynaston H; Division of Cancer and Genetics, Cardiff University Medical School, Cardiff, UK.; Catton CN; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Cross WR; Department of Urology, St James's University Hospital, Leeds, UK.; Petersen PM; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Persad RA; Department of Urology, Bristol Urological Institute, Bristol, UK.; Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.; Bower LC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Logue J; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.; Payne H; The Prostate Centre, London, UK.; Forcat S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Goldstein C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Murphy C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Anderson J; Department of Clinical Oncology, St James's University Hospital, Leeds, UK.; Barkati M; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.; Bottomley DM; Department of Clinical Oncology, St James's University Hospital, Leeds, UK.; Branagan J; Northampton General Hospital, Northampton, UK.; Choudhury A; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK.; Chung PWM; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Cogley L; Derriford Hospital, Plymouth, UK.; Goh CL; Royal Surrey Hospital, Guildford, UK.; Hoskin P; Division of Cancer Sciences, University of Manchester, Manchester, UK; Mount Vernon Cancer Centre, Northwood, UK.; Khoo V; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Malone SC; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.; Masters L; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Morris SL; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Nabid A; Service de Radio-Oncologie, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.; Ong AD; Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.; Raman R; Kent Oncology Centre, Kent and Canterbury Hospital, Canterbury, UK.; Tarver KL; Department of Oncology, Queen's Hospital, Romford, UK.; Tree AC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Worlding J; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.; Wylie JP; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.; Zarkar AM; Department of Oncology, University Hospitals Birmingham, Birmingham, UK.; Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.; Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: mrcctu.radicals@ucl.ac.uk.

Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Parker CC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Kynaston H; Division of Cancer and Genetics, Cardiff University Medical School, Cardiff, UK.; Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Urology, Salford Royal Hospital, Salford, UK.; Catton CN; Princess Margaret Cancer Centre, Toronto, ON, Canada.; Cross WR; Department of Urology, St James's University Hospital, Leeds, UK.; Petersen PM; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Persad RA; Department of Urology, Bristol Urological Institute, Bristol, UK.; Pugh CA; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.; Logue J; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.; Payne H; The Prostate Centre, London, UK.; Bower LC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Brawley C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Rauchenberger M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Barkati M; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.; Bottomley DM; Department of Clinical Oncology, St James's University Hospital, Leeds, UK.; Brasso K; Department of Urology, Copenhagen Prostate Cancer Center, Rigshospitalet, Copenhagen, Denmark.; Chung HT; Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Chung PWM; Princess Margaret Cancer Centre, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Conroy R; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Falconer A; Radiotherapy Department, Charing Cross Hospital, London, UK.; Ford V; Royal Devon and Exeter University NHS Foundation Trust, Exeter, UK.; Goh CL; Royal Surrey County Hospital, Guildford, UK.; Heath CM; Department of Clinical Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.; James ND; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Kim-Sing C; Department of Radiation Oncology, BC Cancer-Vancouver, Vancouver, BC, Canada.; Kodavatiganti R; Glan Clwyd Hospital, Betsi Cadwaladr University Health Board, Bangor, UK.; Malone SC; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.; Morris SL; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Nabid A; Service de Radio-Oncologie, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.; Ong AD; Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.; Raman R; Kent Oncology Centre, Kent and Canterbury Hospital, Canterbury, UK.; Rodda S; Bradford Teaching Hospitals, Bradford, UK.; Wells P; Barts Cancer Centre, St Bartholomew's Hospital, London, UK.; Worlding J; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.; Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.; Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: mrcctu.radicals@ucl.ac.uk.

Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; Health Data Research UK (HDR UK), London, UK; BHF Data Science Centre, Health Data Research UK (HDR UK), London, UK. Electronic address: m.sydes@ucl.ac.uk.; Murray ML; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; Health Data Research UK (HDR UK), London, UK. Electronic address: macey.murray@ucl.ac.uk.; Ahmed S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; UCL Comprehensive Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: saiam.ahmed@ucl.ac.uk.; Apostolidou S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: s.apostolidou@ucl.ac.uk.; Bliss JM; Clinical Trials and Statistics Unit, Division of Clinical Studies, The Institute of Cancer Research, London, UK. Electronic address: judith.bliss@icr.ac.uk.; Bloomfield C; Insitro Inc, San Francisco, CA, USA; NHS Transformation Directorate, NHS England & NHS Improvement, London, UK. Electronic address: cbloomfield@insitro.com.; Cannings-John R; Centre for Trials Research, Cardiff University, Cardiff, UK. Electronic address: canningsrl@cardiff.ac.uk.; Carpenter J; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; London School of Hygiene and Tropical Medicine, London, UK. Electronic address: j.carpenter@ucl.ac.uk.; Clayton T; Department of Medical Statistics and Clinical Trials Unit, London School of Hygiene and Tropical Medicine (LSHTM), London, UK. Electronic address: Tim.Clayton@lshtm.ac.uk.; Clout M; Bristol Trials Centre, University of Bristol, Bristol, UK. Electronic address: madeleine.clout@bristol.ac.uk.; Cosgriff R; NHS Transformation Directorate, NHS England & NHS Improvement, London, UK. Electronic address: r.cosgriff@nhs.net.; Farrin AJ; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK. Electronic address: A.J.Farrin@leeds.ac.uk.; Gentry-Maharaj A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; Department of Women's Cancer, UCL Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK. Electronic address: a.gentry-maharaj@ucl.ac.uk.; Gilbert DC; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: duncan.gilbert@ucl.ac.uk.; Harper C; Nuffield Department of Population Health, University of Oxford, Oxford, UK. Electronic address: charlie.harper@ndph.ox.ac.uk.; James ND; The Institute of Cancer Research, London, UK. Electronic address: nick.james@icr.ac.uk.; Langley RE; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: ruth.langley@ucl.ac.uk.; Lessels S; BHF Data Science Centre, Health Data Research UK (HDR UK), London, UK. Electronic address: Sarah.Lessels@hdruk.ac.uk.; Lugg-Widger F; Centre for Trials Research, Cardiff University, Cardiff, UK. Electronic address: LuggFV@cardiff.ac.uk.; Mackenzie IS; MEMO Research, Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK. Electronic address: i.s.mackenzie@dundee.ac.uk.; Mafham M; Health Data Research UK (HDR UK), London, UK; Nuffield Department of Population Health, University of Oxford, Oxford, UK; Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), NDPH, University of Oxford, Oxford, UK. Electronic address: marion.mafham@ndph.ox.ac.uk.; Menon U; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: u.menon@ucl.ac.uk.; Mintz H; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: HXM074@student.bham.ac.uk.; Pinches H; NHS DigiTrials, NHS England, Leeds, UK. Electronic address: h.pinches@nhs.net.; Robling M; Centre for Trials Research, Cardiff University, Cardiff, UK. Electronic address: Roblingmr@cardiff.ac.uk.; Wright-Hughes A; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK. Electronic address: A.Wright-Hughes@leeds.ac.uk.; Yorke-Edwards V; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; Centre for Advanced Research Computing, University College London, London, UK. Electronic address: v.yorke-edwards@ucl.ac.uk.; Love SB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: s.love@ucl.ac.uk.

Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE

Lensen S; Department of Obstetrics, Gynaecology and Newborn Health, Royal Women's Hospital, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: sarah.lensen@unimelb.edu.au.; Sydes MR; Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom.; Polyakov A; Department of Obstetrics, Gynaecology and Newborn Health, Royal Women's Hospital, University of Melbourne, Melbourne, Victoria, Australia; Reproductive Biology Unit, Royal Women's Hospital, Melbourne, Victoria, Australia.; Wilkinson J; Centre for Biostatistics, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.

Publisher: Elsevier for the American Society for Reproductive Medicine Country of Publication: United States NLM ID: 0372772 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-5653 (Electronic) Linking ISSN: 00150282 NLM ISO Abbreviation: Fertil Steril Subsets: MEDLINE

Ravi P; Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: praful_ravi@dfci.harvard.edu.; Xie W; Dana-Farber Cancer Institute, Boston, MA, USA.; Buyse M; International Drug Development Institute, Louvain-la-Neuve, Belgium; I-BioStat, Hasselt University, Hasselt, Belgium.; Halabi S; Duke University, Durham, NC, USA.; Kantoff PW; Convergent Therapeutics, Cambridge, MA, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Sartor O; Mayo Clinic, Rochester, MN, USA.; Attard G; University College London, London, UK.; Clarke N; The Christie NHS Foundation Trust, Manchester, UK.; D'Amico A; Dana-Farber Cancer Institute, Boston, MA, USA; Brigham & Women's Hospital, Boston, MA, USA.; Dignam J; University of Chicago, Chicago, IL, USA.; James N; The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, London, UK.; Fizazi K; Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.; Gillessen S; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Università della Svizzera Italiana, Lugano, Switzerland.; Parulekar W; Queens University, Kingston, Ontario, Canada.; Sandler H; Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Spratt DE; University Hospitals Siedman Cancer Center, Case Western Reserve University, Cleveland, OH, USA.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Tombal B; Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Williams S; Peter Maccallum Cancer Centre, Melbourne, Australia.; Sweeney CJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia. Electronic address: christopher.sweeney@adelaide.edu.au.

Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

Twine CP; North Bristol NHS Trust and University of Bristol, Bristol, UK; Division of Population Medicine, Cardiff University, Cardiff, UK. Electronic address: Christopher.twine@bristol.ac.uk.; Ahmed H; Centre for Trials Research, Cardiff University, Cardiff, UK.; Lugg-Widger FV; Centre for Trials Research, Cardiff University, Cardiff, UK.; Waldron CA; Centre for Trials Research, Cardiff University, Cardiff, UK.; Bown MJ; Department of Cardiovascular Sciences and the NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trial and Methodology, University College London, London, UK; BHF Data Science Centre, Health Data Research UK, London, UK.

Publisher: Elsevier Country of Publication: England NLM ID: 9512728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2165 (Electronic) Linking ISSN: 10785884 NLM ISO Abbreviation: Eur J Vasc Endovasc Surg Subsets: MEDLINE

James ND; Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: nick.james@icr.ac.uk.; Tannock I; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; N'Dow J; University of Aberdeen, Aberdeen, UK.; Feng F; University of California, San Francisco, USA.; Gillessen S; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Ali SA; University of Manchester, Manchester, UK; The Christie Hospital, Manchester, UK.; Trujillo B; University College London, London, UK.; Al-Lazikani B; MD Anderson Cancer Centre, Houston, TX, USA.; Attard G; University College London, London, UK.; Bray F; International Agency for Research on Cancer, Lyon, France.; Compérat E; Tenon Hospital, Sorbonne University, Paris; AKH Medical University, Vienna, Austria.; Eeles R; Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK.; Fatiregun O; Lagos State University Teaching Hospital, Lagos, Nigeria.; Grist E; University College London, London, UK.; Halabi S; Duke Cancer Institute, Durham, NC, USA.; Haran Á; The Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.; Herchenhorn D; Latin America Cooperative Group, Rio de Janeiro, Brazil.; Hofman MS; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Jalloh M; Université Cheikh Anta Diop de Dakar, Dakar, Senegal.; Loeb S; New York University, New York, NY, USA; Manhattan Veterans Affairs, New York, NY, USA.; MacNair A; University College London, London, UK.; Mahal B; University of Miami, Miami, FL, USA.; Mendes L; University College London, London, UK.; Moghul M; Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK.; Moore C; University College London, London, UK.; Morgans A; Dana Farber Cancer Institute, Boston, MA, USA.; Morris M; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Murphy D; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Murthy V; Tata Memorial Centre, Mumbai, India.; Nguyen PL; Harvard University, Boston, MA, USA.; Padhani A; Mount Vernon Cancer Centre, London, UK.; Parker C; University College London, London, UK.; Rush H; University College London, London, UK.; Sculpher M; University of York, York, UK.; Soule H; Prostate Cancer Foundation, Santa Monica, CA, USA.; Sydes MR; University College London, London, UK.; Tilki D; Martini-Klinik Prostate Cancer Center and Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Koc University Hospital, Istanbul, Türkiye.; Tunariu N; Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK.; Villanti P; Movember, Melbourne, VIC, Australia.; Xie LP; First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Toader AM; MRC-NIHR Trials Methodology Research Partnership, Department of Health Data Science, University of Liverpool, Liverpool, UK. Sgatoade@liverpool.ac.uk.; Campbell MK; Health Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK.; Quint JK; School of Public Health &, National Heart and Lung Institute, Imperial College London, London, UK.; Robling M; Centre for Trials Research, Cardiff University, Cardiff, CF14 4YS, UK.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.; BHF Data Science Centre, Health Data Research UK, London, UK.; Thorn J; Health Economics Bristol, Population Health Sciences, University of Bristol, Bristol, UK.; Wright-Hughes A; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research,, University of Leeds, Leeds, LS2 9JT, UK.; Yu LM; Oxford Primary Care CTU, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Abbott TEF; William Harvey Research Institute, Queen Mary University of London, London, EC1M 6BQ, UK.; Bond S; Cambridge Clinical Trials Unit, Cambridge, UK.; Caskey FJ; BHF Data Science Centre, Health Data Research UK, London, UK.; Clout M; Bristol Trials Centre, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2PS, UK.; Collinson M; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research,, University of Leeds, Leeds, LS2 9JT, UK.; Copsey B; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research,, University of Leeds, Leeds, LS2 9JT, UK.; Davies G; UCL Great Ormond Street Institute of Child Health, London, WC1N 1EH, UK.; Driscoll T; Swansea Trials Unit, Swansea University, Swansea, SA2 8PP, UK.; Gamble C; Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK.; Griffin XL; Barts Bone and Joint Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.; Hamborg T; Pragmatic Clinical Trials Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, E1 2AB, UK.; Harris J; Bristol Trials Centre, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2PS, UK.; Harrison DA; Intensive Care National Audit & Research Centre, London, UK.; Harji D; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research,, University of Leeds, Leeds, LS2 9JT, UK.; Manchester University NHS Foundation Trust, Manchester, UK.; Henderson EJ; Ageing and Movement Research Group, Bristol Medical School, University of Bristol, Bristol, UK.; Older People's Unit, Royal United Hospitals NHS Foundation Trust, Bath, UK.; Logan P; School of Medicine, University of Nottingham and Nottingham City Care Partnership, Nottingham, UK.; Love SB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.; Magee LA; Department of Women and Children's Health, King's College London, London, UK.; O'Brien A; Division of Medicine, UCL Institute for Liver and Digestive Health, Royal Free Campus, Upper 3Rd FloorRowland Hill Street, London, NW3 2PF, UK.; Pufulete M; Bristol Medical School, University of Bristol, Bristol, BS8 2PS, UK.; Ramnarayan P; Department of Surgery and Cancer, Imperial College London, London, W21PB, UK.; Saratzis A; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.; Smith J; Keele Clinical Trials Unit, Faculty of Medicine and Health Sciences, Keele University, Staffordshire, UK.; Solis-Trapala I; Keele Clinical Trials Unit, Faculty of Medicine and Health Sciences, Keele University, Staffordshire, UK.; Stubbs C; Birmingham Clinical Trials Unit (BCTU), Institute of Applied Health Research College of Medical and Dental Sciences, The University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.; Farrin A; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research,, University of Leeds, Leeds, LS2 9JT, UK.; Williamson P; MRC-NIHR Trials Methodology Research Partnership, Department of Health Data Science, University of Liverpool, Liverpool, UK.

Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE